Literature DB >> 26827741

In situ expression of M2 macrophage subpopulation in leprosy skin lesions.

Jorge Rodrigues de Sousa1, Raphael Primo Martins de Sousa1, Tinara Leila de Souza Aarão2, Leonidas Braga Dias3, Francisca Regina Oliveira Carneiro1, Hellen Thais Fuzii3, Juarez Antonio Simões Quaresma4.   

Abstract

The clinical manifestations of the leprosy depend on host immune response and the macrophages are the primary cells involved in this process. M1 and M2 cells exhibited distinct morphology, distinct surface marker profiles, as well as different cytokine and chemokine secretion. Macrophages express receptors such as CD163, CD68, CD206, and costimulatory molecules such as CD80 and CD86, and cytokines that trigger a suppressive or inflammatory response. Thirty-three untreated patients were selected, 17 patients had the tuberculoid leprosy (TT) and 16 had the lepromatous leprosy (LL). We performed immunohistochemistry to detect IL-13, IL-10, TGF-β, FGF-β, CD163, CD68, arginase 1. M2 macrophages showed significant differences between the groups studied with increase in the expression of costimulatory molecules (CD68 and CD163), arginase 1 and cytokines (IL-10, IL-13, TGF-β and FGF-b) in the LL form. Response of M2 macrophages emerge as an alternative for a better understanding of the innate immunity in the polar forms of leprosy, highlighting the role of cytokines, arginase 1 and costimulatory molecules in the repair and suppressive responses in the lepromatous form of the disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical aspect; Immunopathology; M2 macrophage; Macrophage

Mesh:

Substances:

Year:  2016        PMID: 26827741     DOI: 10.1016/j.actatropica.2016.01.008

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  16 in total

Review 1.  Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer.

Authors:  Qi Liu; Wei Sun; Hao Zhang
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

2.  Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.

Authors:  Hayana Ramos Lima; Thaís Helena Gasparoto; Tatiana Salles de Souza Malaspina; Vinícius Rizzo Marques; Marina Jurado Vicente; Elaine Camarinha Marcos; Fabiana Corvolo Souza; Maria Renata Sales Nogueira; Jaison Antônio Barreto; Gustavo Pompermaier Garlet; João Santana da Silva; Vânia Nieto Brito-de-Souza; Ana Paula Campanelli
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 3.  Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.

Authors:  Jorge Rodrigues de Sousa; Mirian Nacagami Sotto; Juarez Antonio Simões Quaresma
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

4.  sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.

Authors:  Ricardo Luís Louzada Silva; Marcio B Santos; Priscila L S Almeida; Thayse S Barros; Lucas Magalhães; Rodrigo A Cazzaniga; Patrícia R M Souza; Nívea F Luz; Jaqueline França-Costa; Valeria M Borges; Djalma S Lima-Junior; Michael W Lipscomb; Malcolm S Duthie; Steven G Reed; Roque Pacheco Almeida; Amélia Ribeiro Jesus
Journal:  PLoS Negl Trop Dis       Date:  2017-03-29

5.  miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.

Authors:  Claudio Guedes Salgado; Pablo Pinto; Raquel Carvalho Bouth; Angélica Rita Gobbo; Ana Caroline Cunha Messias; Tatiana Vinasco Sandoval; André Mauricio Ribeiro Dos Santos; Fabiano Cordeiro Moreira; Amanda Ferreira Vidal; Luiz Ricardo Goulart; Josafá Gonçalves Barreto; Moisés Batista da Silva; Marco Andrey Cipriani Frade; John Stewart Spencer; Sidney Santos; Ândrea Ribeiro-Dos-Santos
Journal:  Front Immunol       Date:  2018-03-09       Impact factor: 7.561

Review 6.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

7.  Serum Levels of Migration Inhibitory Factor (MIF) and In Situ Expression of MIF and Its Receptor CD74 in Lepromatous Leprosy Patients: A Preliminary Report.

Authors:  Marco Alonso Martinez-Guzman; Anabell Alvarado-Navarro; Vidal Delgado-Rizo; Alejandra Garcia-Orozco; Jorge Arturo Mayorga-Rodríguez; Ana Laura Pereira-Suarez; Mary Fafutis-Morris
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

Review 8.  Type I Interferons, Autophagy and Host Metabolism in Leprosy.

Authors:  Thiago Gomes Toledo Pinto; Leonardo Ribeiro Batista-Silva; Rychelle Clayde Affonso Medeiros; Flávio Alves Lara; Milton Ozório Moraes
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

9.  Macrophage Polarization in Leprosy-HIV Co-infected Patients.

Authors:  Tatiana Pereira da Silva; Tamiris Lameira Bittencourt; Ariane Leite de Oliveira; Rhana Berto da Silva Prata; Vinicius Menezes; Helen Ferreira; José Augusto da Costa Nery; Eliane Barbosa de Oliveira; Gilberto Marcelo Sperandio da Silva; Euzenir Nunes Sarno; Roberta Olmo Pinheiro
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

10.  Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions.

Authors:  Jorge Rodrigues de Sousa; Francisco Dias Lucena Neto; Mirian Nacagami Sotto; Juarez Antonio Simões Quaresma
Journal:  BMC Infect Dis       Date:  2018-11-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.